The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BostonGene
Multi-omics analysis of mantle cell lymphoma reveals an immune-cold tumor microenvironment associated with ibrutinib resistance.
 
Krystle Nomie
No Relationships to Disclose
 
Preetesh Jain
No Relationships to Disclose
 
Nikita Kotlov
Employment - BostonGene
Stock and Other Ownership Interests - BostonGene
Patents, Royalties, Other Intellectual Property - Co-author of 1 BostonGene patent
Travel, Accommodations, Expenses - BostonGene
 
Vitaly Segodin
Employment - BostonGene
Patents, Royalties, Other Intellectual Property - yes
Travel, Accommodations, Expenses - BostonGene
 
Qingsong Cai
No Relationships to Disclose
 
Yang Liu
No Relationships to Disclose
 
Lucy Navsaria
No Relationships to Disclose
 
Viktor Svekolkin
Employment - BostonGene
 
Alexander Bagaev
Employment - BostonGene
Stock and Other Ownership Interests - BostonGene
Patents, Royalties, Other Intellectual Property - As an employee of BostonGene
Travel, Accommodations, Expenses - BostonGene
 
Felix Frenkel
Employment - BostonGene
Leadership - BostonGene
Stock and Other Ownership Interests - BostonGene
Patents, Royalties, Other Intellectual Property - I am authors in six patents owned by BostonGene; I am authors in six patents owned by BostonGene
Travel, Accommodations, Expenses - BostonGene
 
Ravshan Ataullakhanov
Employment - BostonGene
 
Nathan Hale Fowler
Employment - BostonGene
Leadership - BostonGene
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche
Research Funding - Celgene; Gilead Sciences; Roche
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - AstraZeneca; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Onclive; oncology business review; Peerview; Pharmacyclics; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; Guidepoint Global; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; More Health; Noble Insights; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Celgene; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; Novartis; Oncternal Therapeutics; Pharmacyclics; VelosBio; Verastem
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries